CS
IPCI

Credit Suisse’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Credit Suisse’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,277
Closed -$188K – 4887
2014
Q1 		$188K Buy
+4,277
New +$171K ﹤0.01% 4373

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Credit Suisse's IPCI Position: Q2 2014 in Review

Credit Suisse sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2014, closing a stake of 4,277 shares — an estimated $188K sold.

Credit Suisse first reported a position in IPCI in Q1 2014 and held it in 1 quarter. The position peaked at $188K in Q1 2014. 19 funds tracked by Wall St. Rank hold IPCI as of Q2 2014.

  • Credit Suisse reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2014 after selling out during the quarter.
  • Credit Suisse sold 4,277 Intellipharmaceuticals International Inc. shares in Q2 2014, an estimated $188K.
  • Credit Suisse first reported a position in Intellipharmaceuticals International Inc. in Q1 2014 and held it in 1 quarter.
  • Credit Suisse's Intellipharmaceuticals International Inc. position peaked at $188K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2014.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.